This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Joint Stock Company "Biocad". Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Arina Vitalevna Anikina: Innovator in Monoclonal Antibody Development
Introduction
Arina Vitalevna Anikina is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents, her work focuses on innovative solutions for treating diseases associated with the human T cell receptor family.
Latest Patents
Anikina's latest patents include groundbreaking inventions related to monoclonal antibodies that specifically bind to the TRBV9 family of the human T cell receptor. One of her notable patents describes a monoclonal humanized antibody or antigen-binding fragment that targets the TRBV9 family. This invention encompasses a nucleic acid encoding the antibody, an expression vector, and methods for preparing the antibody. It also highlights the use of the antibody in treating diseases such as ankylosing spondylitis, celiac disease, and malignant blood diseases linked to the TRBV9 family T cell receptors. Another patent focuses on monoclonal antibodies against the beta chain region of human TRBV9, further emphasizing her commitment to advancing therapeutic options in this area.
Career Highlights
Throughout her career, Anikina has demonstrated a strong dedication to research and innovation. Her work has not only contributed to the scientific community but has also paved the way for potential treatments that could improve patient outcomes in various medical conditions.
Collaborations
Anikina has collaborated with notable colleagues, including Pavel Andreevich Iakovlev and Mariia Aleksandrovna Shchemeleva. These partnerships have enhanced her research efforts and expanded the impact of her inventions.
Conclusion
Arina Vitalevna Anikina stands out as a leading inventor in the field of monoclonal antibody development. Her innovative patents and collaborative efforts reflect her commitment to advancing medical science and improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile